Neuroendocrine Serum Tumour Markers in Hormone-Resistant Prostate Cancer

Author： Hvamstad T. Jordal A. Hekmat N. Paus E. Fossa S.D.

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.44, Iss.2, 2003-08, pp. : 215-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancer

By Oliver R.T.D. Williams G. Paris A.M.I. Blandy J.P.

Urology, Vol. 49, Iss. 1, 1997-01 ,pp. : 79-82

Elsevier

Access to resources Recommend Favorite

Sequential chemotherapy with estramustine and vinorelbine for tumour cell synchronization in hormone refractory prostate cancer

By Kramer G. Steiner G. Herbst W. Sokol P. Zielinski C. Djavan B. Marberger M.

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 25-25

Elsevier

Access to resources Recommend Favorite

Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer

By Kohli M. Kaushal V. Spencer H.J. Mehta P.

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 765-769

Elsevier

Access to resources Recommend Favorite

Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer

By Noguchi M. Yahara J. Noda S.

Urology, Vol. 61, Iss. 5, 2003-05 ,pp. : 993-998

Elsevier

Access to resources Recommend Favorite

Prostate cancer with a normal PSA - is it an insignificant tumour?

By Bader P. Muller J. Huber R.D. Echtle D. Frohneberg D.

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 132-132

Elsevier

Access to resources Recommend Favorite